Tradestie Institutional Equity Comparison Engine

MTVA vs WOK โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

MTVA Overall Edge

MTVA Captures Institutional Edge (2โ€“0 Pillars ยท 3โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to MetaVia Inc. Common Stock (MTVA) driven by superior Growth & Margin, Momentum & Technical. Fundamentally, MTVA trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus WOK at N/M Forward P/E and -41.7% operating margin (+19.1% YoY). In options structure, MTVA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against WOK sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
MTVA N/M vs WOK N/M Fwd P/E
Growth & Margin Winner MTVA
Op Margin 0.0% vs -41.7% ยท YoY +0.0% vs +19.1%
Momentum & Technical Winner MTVA
1Y +32.2% vs -72.3% ยท 52W Pos 4% vs 14%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
MTVA NASDAQ
MetaVia Inc. Common Stock
Pharmaceutical Preparations
$1.01
-5.61% 1D
Market Cap $7.2M
1M Return -27.34%
1Y Return +32.2%
Forward P/E N/M
Unified AI Score
48.0 / 100 HOLD
Tech 40.0 Fund 60.0 Flow 50.0 Mom 64.0
WOK NASDAQ
WORK Medical Technology Group LTD Class A Ordinary Shares
Surgical & Medical Instruments & Apparatus
$1.10
-5.13% 1D
Market Cap $5.2M
1M Return -3.04%
1Y Return -72.26%
Forward P/E N/M
Unified AI Score
31.4 / 100 SELL
Tech 15.0 Fund 34.0 Flow 50.0 Mom 44.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: MTVA +32.2% WOK -72.26% Spread: +104.46 pp (MTVA Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
MTVA TTM Op. Margin: 0.0% WOK TTM Op. Margin: -41.7%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on MTVA vs WOK. Trailing 12-month operating profitability (MTVA 0.0% vs WOK -41.7%) and valuation multiples (MTVA N/M vs WOK N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: MTVA (3) vs WOK (4)
Institutional Metric MTVA WOK Criterion Row Winner
Market Capitalization Scale $7.2M $5.2M Larger Scale Tie
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +0.0% +19.1% Higher Growth WOK
Operating Margin (TTM) Profitability 0.0% -41.7% Higher Margin MTVA
Net Profit Margin Profitability 0.0% -41.9% Higher Margin MTVA
Return on Equity (ROE) Capital Efficiency -175.7% -19.2% Higher ROE WOK
52-Week Range Position Momentum 4% ($1โ€“$13) 14% ($0โ€“$7) Stronger Trend WOK
Beta / 30D Volatility Risk Regime 1.30ฮฒ ยท 166% Vol 37.03ฮฒ ยท 149% Vol Lower Realized Risk WOK
Unified Institutional Score Composite Signal 48.0 / 100 (HOLD) 31.4 / 100 (SELL) Higher Composite MTVA

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full MTVA vs WOK Buy Guide
MTVA UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live MTVA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
WOK UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live WOK Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither MTVA nor WOK registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.